This inhibition reverses aberrant PIK3CD-S to PIK3CD-L, sensitizing the AA PCa cells to PI3K/PI3Kδ inhibitors, suggesting a synergistic approach to targeting PIK3CD-S-expressing PCa cells. Here, PIK3CB is linked to posterior cortical atrophy.